GOLGA8K Activators
GOLGA8K Activators encompass a selection of chemical compounds that foster the functional activity of GOLGA8K by orchestrating various cellular signaling cascades. Forskolin exemplifies this by escalating cAMP levels, thereby amplifying PKA activity which can phosphorylate proteins that interact with GOLGA8K, facilitating its role in the Golgi apparatus. Similar upregulation of PKA is achieved through 8-Bromo-cAMP and 6-Bnz-cAMP, both cAMP analogs that permeate cells and selectively activate PKA, leading to potential enhancements in GOLGA8K's involvement in protein sorting. Epigallocatechin gallate, by inhibiting competitive protein kinases, and Thapsigargin, by raising cytosolic calcium levels and triggering calcium-dependent signaling, may also indirectly underpin the activity of GOLGA8K within theGolgi apparatus. Further, the activation of PKC by Phorbol 12-myristate 13-acetate (PMA) and the modulation of lipid signaling by Sphingosine-1-phosphate (S1P) are other examples of indirect enhancement of GOLGA8K's functionality, as these pathways can lead to phosphorylation events and cytoskeletal rearrangements that support the structural integrity and operation of the Golgi apparatus where GOLGA8K resides.
The regulatory landscape of GOLGA8K is further influenced by compounds like Ionomycin and Brefeldin A, which affect calcium levels and Golgi apparatus structure respectively, potentially resulting in an increased reliance on GOLGA8K's role in maintaining Golgi dynamics. The use of kinase inhibitors such as LY294002 and Wortmannin, which perturb PI3K/AKT signaling, and U0126, a MEK1/2 inhibitor, may also redirect cellular signaling in a manner that favors the enhancement of GOLGA8K's function within the Golgi apparatus. These compounds collectively represent a chemical toolkit that, by acting on discrete signaling pathways, indirectly but effectively amplify the functional activity of GOLGA8K without necessitating its direct activation or increased expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase leading to an increase in cyclic AMP (cAMP) levels, which can indirectly enhance GOLGA8K function by promoting protein kinase A (PKA) activity. PKA can then phosphorylate various downstream targets that could interact with GOLGA8K, thereby enhancing its activity in the Golgi apparatus. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate, a polyphenol found in green tea, inhibits multiple protein kinases. This inhibition can reduce competitive signaling and may allow GOLGA8K to function more effectively in Golgi maintenance and protein trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can result in the phosphorylation of proteins involved in Golgi organization, potentially enhancing the role of GOLGA8K in Golgi structure maintenance. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, which can lead to actin cytoskeleton rearrangements. These rearrangements are important for Golgi apparatus function, and thus could indirectly enhance the activity of GOLGA8K. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate proteins associated with the Golgi apparatus, potentially enhancing GOLGA8K's role in protein sorting and trafficking. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent protein kinases and potentially influencing the Golgi apparatus' structure and function, thereby indirectly enhancing GOLGA8K activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which may activate calcium-dependent signaling, influencing the Golgi apparatus where GOLGA8K is localized and potentially enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that modulates AKT signaling. By inhibiting PI3K, the balance of signaling pathways can shift, potentially enhancing GOLGA8K's role in Golgi apparatus maintenance and vesicle trafficking. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which could shift signaling pathways in favor of those that promote Golgi apparatus functions, thereby indirectly enhancing GOLGA8K's activity in the cell. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus structure by inhibiting ADP-ribosylation factor, which could lead to a compensatory enhancement of GOLGA8K activity as the cell attempts to maintain Golgi integrity. | ||||||